Metabolic changes in the knockout mouse for Canavan's disease: Implications for patients with Canavan's disease

Journal of Child Neurology

Volumn 18, Issue 9, 2003, Pages 611-615

  Surendran, Sankar ^a   Matalon, Kimberlee M ^a   Szucs, Sylvia ^a   Trying, Stephen K ^a   Matalon, Reuben ^a  

^a UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID; ASPARTATE AMINOTRANSFERASE; ASPARTIC ACID; ASPARTOACYLASE; GLUTAMIC ACID; MALIC ACID; N ACETYLASPARTIC ACID;

AMINO ACID ANALYSIS; AMINO ACID BRAIN LEVEL; ARTICLE; BODY FAT; BODY WEIGHT; BONE DENSITY; BONE MINERAL; BRAIN SPONGIOSIS; CANAVAN DISEASE; CROWN RUMP LENGTH; DUAL ENERGY X RAY ABSORPTIOMETRY; ENZYME ACTIVITY; ENZYME DEFICIENCY; HEAD CIRCUMFERENCE; HUMAN; INFANT; KNOCKOUT MOUSE; METABOLIC PARAMETERS; MOUSE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL;

EID: 0141962686     PISSN: 08830738     EISSN: None     Source Type: Journal    
DOI: 10.1177/08830738030180090701     Document Type: Article

References (40)

1. Matalon R, Michals K, Sebesta D, et al: Aspartoacylase deficiency and N-acetylaspartic aciduria in patients with Canavan disease. Am J Med Genet 1988;29:463-471.
2. Canavan MM: Schilder's encephalitis periaxialis diffusa. Arch Neurol Psychiatry 1931;25:299-308.
3. van Bogaert L, Bertrand I: Sur une idiote familiale avec degenerescence spongieuse de neuraxe (note preliminaire). Acta Neurol Belg 1949;12:572-587.
4. Matalon R, Kaul R, Michals K: Canavan disease: Biochemical and molecular studies. J Inherit Metab Dis 1993;16:744-752.
5. Matalon R, Kaul R, Michals K: Spongy degeneration of the brain: Canavan disease, in Duckett S (ed): Pediatric Neuropathology. Baltimore, Williams & Wilkins, 1995, 625-629.
6. Matalon R, Kaul R, Michals K: Canavan disease: From spongy degeneration to molecular analysis. J Pediatr 1995;127:511-517.
7. Banker BQ, Victor H: Spongy degeneration of infancy, in Goodman RM, Motulsky AG (eds): Genetic Diseases Among Ashkenazi Jews. New York, Raven Press, 1979, 201-217.
8. Matalon R: Canavan disease: Diagnosis and molecular analysis. Genet Test 1997;1:21-25.
9. Matalon RM, Michals-Matalon K: Spongy degeneration of the brain, Canavan disease: Biochemical and molecular findings. Front Biosci 2000;5:D307-D311.
10. Matalon R, Rady PL, Platt KA, et al: Knock-out mouse for Canavan disease: A model for gene transfer to the central nervous system. J Gene Med 2000;2:165-175.
11. Petroff OA, Hyder F, Mattson RH, Rothman DL: Topiramate increases brain GABA, homocarnosin and pyrolidone in patients with epilepsy. Neurology 1999;52:473-478.
12. Bhakoo KK, Craig TJ, Styles P: Developmental and regional distribution of aspartoacylase in rat brain tissue. J Neurochem, 2001;79:211-220.
13. Bergmeyer HU, Scheibe P, Wahlfeld AW: Optimization of methods for aspartate aminotransferase. Clin Chem 1978;24:58-73.
14. Saad AY: Postnatal effects of nicotine on incisor development of albino mouse. J Oral Pathol Med 1990;19:426-429.
15. Wimalwansa SJ, De Marco G, Gangula P, Yallampalli C: Nitric oxide donor alleviates ovariectomy-induced bone loss. Bone 1996;18:301-304.
16. Wimalawansa SJ, Surendran S, Wimalawansa D, et al: Dose response and the comparison of oral vs. parenteral vitamin E (alpha tocopherol) in prevention of ovariectomy-induced bone loss in rat. J Bone Miner Res 2000;15:S554.
17. Goodman SI, Markey SP: Diagnosis of Organic Acidemias by Gas Chromatography-Mass Spectrometry. New York, Alan R. Liss, 1981.
18. Knore R, Assmann D, Landwehrmeyer B, et al: Aspartate, glutamate, glycine and γ-aminobutyric acid in human bioptic neocortical areas: Comparison to autoptic tissue. Neurosci Lett 1997;221:169-172.
19. Cooms MW: Amino acid metabolism, in Devlin TM (ed): Textbook of Biochemistry with Clinical Correlations. New York, Wiley Liss, 1997, 445-488.
20. Newsholme P, Procopio J, Lima MMR, Pithon-Curi TC: Glutamine and glutamate - Their central role in cell metabolism and function. Cell Biochem Funct 2003;21:1-9.
21. Sturk A, Sanders GTB: Macro-enzymes: Prevalence, composition, detection and clinical relevance. J Clin Chem Clin Biochem 1990;28:65-81.
22. Ramaley AT, Wilding P: Macroenzymes: Biochemical characterization, clinical significance and laboratory detection. Clin Chem 1989;35:2261-2270.
23. 15H] glutamate by cultured astrocytes. Biochem J 1986;234:185-192.
24. Strecker HJ: Metabolic reactions in the nervous system, in Lajtha A (ed): Protein Metabolism of the Nervous System. New York, Plenum Press, 1970, 173.
25. Tews JK, Lovell RA: The effect of a nutritional pyridixine deficiency on free aminoacids and related substances in mouse brain. J Neurochem 1967;14:1-7.
26. 6 Pyridoxal Phosphate. Chemical, Biochemical and Medical Aspects. New York, John Wiley & Sons Inc, 1986, 545-551.
27. 6 dependent enzymes of glutamate, gamma-aminobutyrate and glutamine systems in rat brain. Exp Gerontol 1984;19:87-93.
28. Baslow MH: Molecular water pumps and the aetiology of Canavan disease: A case of the sorcerer's apprentice. J Inherit Metab Dis 1999;22:99-101.
29. Baslow MH: The existence of molecular water pumps in the nervous system. A review of the evidence. Neurochem Int 1999; 34:77-90.
30. Singal P, Sidhu LS, Bhatnagar DP: Estimated fat, bone mineral, total body water in cell solids in females of two communities of Punjab, India. Anthropol Anz 1988;46:51-57.
31. Rosso P: Prenatal nutrition and fetal growth and development. Pediatr Ann 1981;10:21-30.
32. Michael R, Rudolf L: The physiology of body weight regulation: Relevance to the etiology of obesity in children. Pediatrics 1998;101:525-539.
33. Douchi T, Kuwahata R, Matsuo T, et al: Relative contribution of lean and fat mass component to bone mineral density in males. J Bone Miner Metab 2003;21:17-21.
34. Blum M, Harris A, Must A, et al: Weight and body mass index at menarche are associated with premenopausal bone mass. Osteoporos Int 2001;12:588-594.
35. Bedogni G, Mussi C, Malavolti M, et al: Relationship between body composition and bone mineral content in young and elderly women. Ann Hum Biol 2002;29:559-565.
36. Douchi T, Yamamoto S, Nakamura S, et al: Lean mass as a significant determinant of regional and total body bone mineral density in premenopausal women. J Bone Miner Metab 1998;16:17-20.
37. Douchi T, Yamamoto S, Kuwahata R, et al: Effect of non-weight bearing fat on bone mineral density before and after menopause. Obstet Gynecol 2000;96:13-17.
38. Kanumakala S, Boneh A, Zacharin M: Pamidronate treatment improves bone mineral density in children with Menkes disease. J Inherit Metab Dis 2002;25:391-398.
39. Matarazzo P, Lala R, Masi G, et al: Pamidronate treatment in bone fibrous dysplasia in children and adolescents with McCune-Albright syndrome. J Pediatr Endocrinol Metab 2002; 15(Suppl 3):929-937.
40. Judex S, Donahue LR, Rubin C: Genetic predisposition to low bone mass is paralleled by an enhanced sensitivity to signals anabolic to the skeleton. FASEB J 2002;16:1280-1282.